These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28377212)

  • 1. Differentiating true androgen receptor inhibition from cytotoxicity-mediated reduction of reporter-gene transactivation in-vitro.
    Marin-Kuan M; Fussell KC; Riederer N; Latado H; Serrant P; Mollergues J; Coulet M; Schilter B
    Toxicol In Vitro; 2017 Dec; 45(Pt 3):359-365. PubMed ID: 28377212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation.
    Freyberger A; Witters H; Weimer M; Lofink W; Berckmans P; Ahr HJ
    Reprod Toxicol; 2010 Aug; 30(1):9-17. PubMed ID: 19836445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds.
    van der Burg B; Winter R; Man HY; Vangenechten C; Berckmans P; Weimer M; Witters H; van der Linden S
    Reprod Toxicol; 2010 Aug; 30(1):18-24. PubMed ID: 20438827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and pre-validation of an in vitro transactivation assay for detection of (anti)androgenic potential compounds using 22Rv1/MMTV cells.
    Sun S; Park EJ; Choi YH; Lee HS; Ahn BY; Dong MS
    Reprod Toxicol; 2016 Apr; 60():156-66. PubMed ID: 26867867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Endocrine and Dioxin-Like Activity of Extracts of Petroleum Substances in Developmental Toxicity as Detected in a Panel of CALUX Reporter Gene Assays.
    Kamelia L; Louisse J; de Haan L; Maslowska-Gornicz A; Ketelslegers HB; Brouwer A; Rietjens IMCM; Boogaard PJ
    Toxicol Sci; 2018 Aug; 164(2):576-591. PubMed ID: 29726971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities.
    Sonneveld E; Riteco JA; Jansen HJ; Pieterse B; Brouwer A; Schoonen WG; van der Burg B
    Toxicol Sci; 2006 Jan; 89(1):173-87. PubMed ID: 16221957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of estrogenic and anti-androgenic activities of the mycotoxin zearalenone and its metabolites using in vitro receptor-specific bioassays.
    Molina-Molina JM; Real M; Jimenez-Diaz I; Belhassen H; Hedhili A; Torné P; Fernández MF; Olea N
    Food Chem Toxicol; 2014 Dec; 74():233-9. PubMed ID: 25455890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of estrogen and androgen activity of food contact materials by different in vitro bioassays (YES, YAS, ERα and AR CALUX) and chromatographic analysis (GC-MS, HPLC-MS).
    Mertl J; Kirchnawy C; Osorio V; Grininger A; Richter A; Bergmair J; Pyerin M; Washüttl M; Tacker M
    PLoS One; 2014; 9(7):e100952. PubMed ID: 25000404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol.
    Klopčič I; Markovič T; Mlinarič-Raščan I; Sollner Dolenc M
    Toxicol Lett; 2018 Sep; 294():95-104. PubMed ID: 29777833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ability of the YAS and AR CALUX assays to detect the additive effects of anti-androgenic fungicide mixtures.
    Seeger B; Klawonn F; Bekale BN; Steinberg P
    Toxicol Lett; 2016 Jan; 241():193-9. PubMed ID: 26602169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays.
    Kim HJ; Park YI; Dong MS
    Toxicol In Vitro; 2006 Oct; 20(7):1159-67. PubMed ID: 16621434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of mixture effects of endocrine active substances in wastewater using CALUX reporter-gene assays.
    Pannekens H; Gottschlich A; Hollert H; Dopp E
    Int J Hyg Environ Health; 2019 May; 222(4):670-677. PubMed ID: 31129136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending an in vitro panel for estrogenicity testing: the added value of bioassays for measuring antiandrogenic activities and effects on steroidogenesis.
    Wang S; Rijk JC; Besselink HT; Houtman R; Peijnenburg AA; Brouwer A; Rietjens IM; Bovee TF
    Toxicol Sci; 2014 Sep; 141(1):78-89. PubMed ID: 24928889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro investigation on the cytotoxic and nuclear receptor transcriptional activity of the mycotoxins fumonisin B1 and beauvericin.
    Fernández-Blanco C; Frizzell C; Shannon M; Ruiz MJ; Connolly L
    Toxicol Lett; 2016 Aug; 257():1-10. PubMed ID: 27234500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine toxicology--contributions of in vitro methods to the 3R concept.
    Freyberger A; Scholz G
    ALTEX; 2004; 21 Suppl 3():20-7. PubMed ID: 15057405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual and combined in vitro (anti)androgenic effects of certain food additives and cosmetic preservatives.
    Pop A; Drugan T; Gutleb AC; Lupu D; Cherfan J; Loghin F; Kiss B
    Toxicol In Vitro; 2016 Apr; 32():269-77. PubMed ID: 26812027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of endocrine disruption potential of essential oils of culinary herbs and spices involving glucocorticoid, androgen and vitamin D receptors.
    Bartoňková I; Dvořák Z
    Food Funct; 2018 Apr; 9(4):2136-2144. PubMed ID: 29629442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference of endocrine disrupters with thyroid hormone receptor-dependent transactivation.
    Hofmann PJ; Schomburg L; Köhrle J
    Toxicol Sci; 2009 Jul; 110(1):125-37. PubMed ID: 19403856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human blood-based exposure levels of persistent organic pollutant (POP) mixtures antagonise androgen receptor transactivation and translocation.
    McComb J; Mills IG; Muller M; Berntsen HF; Zimmer KE; Ropstad E; Verhaegen S; Connolly L
    Environ Int; 2019 Nov; 132():105083. PubMed ID: 31470217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic depsipeptide mycotoxin exposure may cause human endocrine disruption: Evidence from OECD in vitro stably transfected transcriptional activation assays.
    Park Y; Lee HS
    Reprod Toxicol; 2021 Mar; 100():52-59. PubMed ID: 33346041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.